retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Diagram showing the mechanism of action of Retatrutide vs. Tirzepatide: The Next-Gen

Dulaglutide: Brand name Trulicity FDA approved for Type 2 Diabetes Mellitus (T2DM) and requires a PA with chart notes documenting diagnosis (confirmed with lab values) and trial and failure with 30 days of metformin or another antidiabetic drug

(US) Innovent Biologics (China) Shanghai Benemae Pharmaceutical (China) PegBio Co Ltd

[DOI] [PubMed] [Google Scholar] 257.Nuffer W.A., Trujillo J.M

What is the real cost of GLP-1 medications for obesity

Alicuben ET, Samaan JS, Houghton CC, Soffer E, Lipham JC, Samakar K (2021) Sleeve gastrectomy as a novel procedure for gastroparesis

Common side effects and safety considerations All three medications can cause nausea, vomiting, diarrhea, and constipation, especially during dose titration